Literature DB >> 27684040

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.

Valerio Rossini1, Katarina Radulovic2, Christian U Riedel3, Jan Hendrik Niess4.   

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammation which affects the gastrointestinal tract (GIT). One of the best ways to study the immunological mechanisms involved during the disease is the T cell transfer model of colitis. In this model, immunodeficient mice (RAG(-/-) recipients) are reconstituted with naive CD4(+) T cells from healthy wild type hosts. This model allows examination of the earliest immunological events leading to disease and chronic inflammation, when the gut inflammation perpetuates but does not depend on a defined antigen. To study the potential role of antigen presenting cells (APCs) in the disease process, it is helpful to have an antigen-driven disease model, in which a defined commensal-derived antigen leads to colitis. An antigen driven-colitis model has hence been developed. In this model OT-II CD4(+) T cells, that can recognize only specific epitopes in the OVA protein, are transferred into RAG(-/-) hosts challenged with CFP-OVA-expressing E. coli. This model allows the examination of interactions between APCs and T cells in the lamina propria.

Entities:  

Mesh:

Year:  2016        PMID: 27684040      PMCID: PMC5092027          DOI: 10.3791/54421

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  52 in total

Review 1.  Intestinal dysbiosis in inflammatory bowel disease.

Authors:  Nirmal Kaur; Chun-Chia Chen; Jay Luther; John Y Kao
Journal:  Gut Microbes       Date:  2011-07-01

2.  Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.

Authors:  Fermín Capitán-Cañadas; Borja Ocón; Carlos José Aranda; Andrea Anzola; María Dolores Suárez; Antonio Zarzuelo; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

Review 3.  Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense.

Authors:  Julia Farache; Ehud Zigmond; Guy Shakhar; Steffen Jung
Journal:  Immunol Cell Biol       Date:  2013-02-12       Impact factor: 5.126

4.  T cell-induced inflammation of the small and large intestine in immunodeficient mice.

Authors:  Dmitry V Ostanin; Kevin P Pavlick; Sulaiman Bharwani; Dwain D'Souza; Kathryn L Furr; Carla M Brown; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-08-11       Impact factor: 4.052

5.  Intestinal microbiota in inflammatory bowel disease: friend of foe?

Authors:  Francesca Fava; Silvio Danese
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 6.  Contribution of microbial amino acids to amino acid homeostasis of the host.

Authors:  C C Metges
Journal:  J Nutr       Date:  2000-07       Impact factor: 4.798

7.  Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.

Authors:  Julia Farache; Idan Koren; Idan Milo; Irina Gurevich; Ki-Wook Kim; Ehud Zigmond; Glaucia C Furtado; Sergio A Lira; Guy Shakhar
Journal:  Immunity       Date:  2013-02-07       Impact factor: 31.745

Review 8.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  The gut microbiota and mucosal T cells.

Authors:  Patrick M Smith; Wendy S Garrett
Journal:  Front Microbiol       Date:  2011-05-26       Impact factor: 5.640

10.  Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis.

Authors:  Leo R Fitzpatrick
Journal:  Int J Inflam       Date:  2012-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.